Orion, Bayer prostate cancer drug gets FDA approval

Finland's Orion and Germany's Bayer said on Wednesday the U.S. Food and Drug Administration (FDA) had approved prostate cancer drug daroluramide, which the two companies have been developing together.


from Reuters: Health News https://ift.tt/2Mu4xKP

Comments

Popular posts from this blog

PSL 2018: DWP Group becomes title sponsor of Lahore Qalandars

Tonga bans rugby, boxing for girls 'to preserve dignity'